November 1, 2022 06:59 AM EDTUpdated 07:12 AM
Bioregnum

Drew Arm­strong is com­ing to End­points(!) And there are some more sur­pris­es to come

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Who pays the most in bio­phar­ma? We an­a­lyzed me­di­an pay at 177 com­pa­nies

Up­dat­ed: Mer­ck drops $10B for res­pi­ra­to­ry drug­mak­er Verona Phar­ma in its first ac­qui­si­tion of 2025

Fed­er­al judge sides with FDA on its mifepri­s­tone safe­ty pro­gram

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Q&A: Re­tir­ing Arv­inas CEO John Hous­ton talks PRO­TACs, in­vestor con­fi­dence and what’s next with Pfiz­er

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times